MyFinsight

HomeBlogAbout

MyFinsight

Making company financials insightful for everyone

  • About
  • Blog
  • Privacy Policy
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

Balance Sheets Overview

Current Ratio
187.30%
Quick Ratio
187.30%
Cash Ratio
172.99%
Debt to Asset Ratio
52.15%
Unit: Thousand (K) dollars
Assets Breakdown
    • Cash and cash equivalents
    • Intangible assets, net
    • Operating lease right-of-use ass...
    • Others
Liabilities Breakdown
    • Additional paid-in capital
    • Accumulated deficit
    • Accounts payable
    • Others
Balance Sheets
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Cash and cash equivalents
15,765
19,851
20,734
21,418
Short-term investments
-
5,130
10,077
15,042
Prepaid expenses and other current assets
1,304
345
727
1,983
Total current assets
17,069
25,326
31,538
38,443
Property and equipment, net
36
44
52
60
Intangible assets, net
291
306
322
338
Operating lease right-of-use assets
104
124
144
163
Other non-current assets
17
17
17
17
Total assets
17,517
25,817
32,073
39,021
Accounts payable
4,638
4,620
3,219
4,078
Accrued expenses
4,352
6,518
7,707
6,849
Operating lease liabilities, current portion
123
120
116
113
Total current liabilities
9,113
11,258
11,042
11,040
Operating lease liabilities, net of current portion
22
54
85
115
Total liabilities
9,135
11,312
11,127
11,155
Common stock, 0.001 par value 150,000,000 shares authorized as of june 30, 2026 and december 31, 2025 9,381,344 shares issued and outstanding as of june 30, 2026 and december 31, 2025
9
9
9
9
Additional paid-in capital
132,084
131,749
131,379
131,025
Accumulated other comprehensive income
-
1
8
7
Accumulated deficit
-123,711
-117,254
-110,450
-103,175
Total stockholders' equity
8,382
14,505
20,946
27,866
Total liabilities and stockholders' equity
17,517
25,817
32,073
39,021
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Cash and cashequivalents$15,765K (-23.65%↓ Y/Y)Prepaid expenses andother current assets$1,304K (-38.95%↓ Y/Y)Total current assets$17,069K (-60.42%↓ Y/Y)Intangible assets, net$291K (-17.80%↓ Y/Y)Operating leaseright-of-use assets$104K (-42.54%↓ Y/Y)Property and equipment,net$36K (-47.06%↓ Y/Y)Other non-currentassets$17K (0.00%↑ Y/Y)Total assets$17,517K (-59.96%↓ Y/Y)Total liabilities andstockholders' equity$17,517K (-59.96%↓ Y/Y)Total liabilities$9,135K (-15.60%↓ Y/Y)Total stockholders'equity$8,382K (-74.54%↓ Y/Y)Accumulated deficit-$123,711K (-26.69%↓ Y/Y)Total currentliabilities$9,113K (-14.66%↓ Y/Y)Operating leaseliabilities, net of current...$22K (-84.83%↓ Y/Y)Additional paid-in capital$132,084K (1.15%↑ Y/Y)Common stock, 0.001 parvalue 150,000,000...$9K (0.00%↑ Y/Y)Accounts payable$4,638K (91.26%↑ Y/Y)Accrued expenses$4,352K (-46.56%↓ Y/Y)Operating leaseliabilities, current portion$123K (212.84%↑ Y/Y)

Tvardi Therapeutics, Inc. (TVRD)

Tvardi Therapeutics, Inc. (TVRD)